Elsa L S A van Liere

9PUBLICATIONS
14CO-AUTHORS
Liquid biopsiesCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 22, 2026
Urinary and Faecal Amino-Acids as Biomarkers for Colorectal Neoplasia in Lynch Syndrome-A Prospective Longitudinal Study.

|Sep 23, 2025
The diagnostic potential of urinary volatile organic compounds for colorectal neoplasia in Lynch syndrome-A prospective longitudinal study.

Elsa L S A van Liere, Dewkoemar Ramsoekh, Trenton K Stewart

|Oct 18, 2024
Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome-A Prospective Longitudinal Multicentre Study.

Elsa L S A van Liere, Dewkoemar Ramsoekh, Emma Daulton

|Aug 20, 2024
Fecal Immunochemical Test to Detect Colorectal Neoplasia in Lynch Syndrome: A Prospective Multicenter Study.

Elsa L S A van Liere, Nanne K H de Boer, Monique E van Leerdam

|Feb 19, 2022
Systematic review: non-endoscopic surveillance for colorectal neoplasia in individuals with Lynch syndrome.

Elsa L S A van Liere, Nanne K H de Boer, Evelien Dekker

|Nov 03, 2021
Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases.

Elsa L S A van Liere, Ahmed B Bayoumy, Chris J J Mulder

Pageof 2

Frequent Collaborators

3 joint publications

Manon C W Spaander

2 joint publications

Nanne K H de Boer

2 joint publications

Monique E van Leerdam

2 joint publications

Evelien Dekker